Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07188064 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery

Study acronym: PRP NG PRO M
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2025 to Jan 30, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A single arm prospective pilot trial evaluating the 1-year erectile recovery outcomes and the safety of patients undergoing a somatic to autonomic nerve grafting procedure for restoration of erectile function in patients who have lost erectile function following radical prostatectomy for prostate cancer. During this study a total of 100 patients who have persistent erectile dysfunction for more than 18 months post prostatectomy will undergo a post radical prostatectomy nerve restoration procedure (PRP-NR).
Trial Details
NCT Number NCT07188064
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Collaborators: McGill University Health Centre/Research Institute of the McGill University Health Centre, Western University, Canada, Fox Chase Cancer Center
Conditions
(from sponsor)		 Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy
Related terms Prostatic Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov